The role of cystatin A in breast cancer and its functional link with ERα

Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati 781039, India

More Information

Corresponding author: E-mail address: amul@iitg.ernet.in (Anil M. Limaye)

摘要

HTML全文

参考文献(32)

[1]	Alavaikko, M., Aine, R., Rinne, A. et al. Behaviour of dendritic reticulum cells possessing immunoreactive acid cysteine-proteinase inhibitor in human lymphoid secondary follicles and in follicular-centre cell lymphomas Int. J. Cancer, 35 (1985),pp. 319-325
[2]	Björklund, H.V., Johansson, T.R., Rinne, A. Rhabdovirus-induced apoptosis in a fish cell line is inhibited by a human endogenous acid cysteine proteinase inhibitor J. Virol., 71 (1997),pp. 5658-5662
[3]	Browne, G., Taipaleenmäki, H., Bishop, N.M. et al. J. Cell. Physiol., 230 (2015),pp. 2522-2532
[4]	Chimge, N.-O., Frenkel, B. The RUNX family in breast cancer: relationships with estrogen signaling Oncogene, 32 (2013),pp. 2121-2130
[5]	Davies, M.E., Barrett, A.J. Immunolocalization of human cystatins in neutrophils and lymphocytes Histochemistry, 80 (1984),pp. 373-377
[6]	Eide, T.J., Järvinen, M., Hopsu-Havu, V.K. et al. Immunolocalization of cystatin A in neoplastic, virus and inflammatory lesions of the uterine cervix Acta Histochem., 93 (1992),pp. 241-248
[7]	Estrada, S., Nycander, M., Hill, N.J. et al. The role of Gly-4 of human cystatin A (Stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with Papain, Cathepsin B, and Cathepsin L Biochemistry, 37 (1998),pp. 7551-7560
[8]	Green, G.D., Kembhavi, A.A., Davies, M.E. et al. Cystatin-like cysteine proteinase inhibitors from human liver Biochem. J., 218 (1984),pp. 939-946
[9]	Guenette, R.S., Mooibroek, M., Wong, K. et al. Cathepsin B, a cysteine protease implicated in metastatic progression, is also expressed during regression of the rat prostate and mammary glands Eur. J. Biochem., 226 (1994),pp. 311-321
[10]	Györffy, B., Lanczky, A., Eklund, A.C. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients Breast Cancer Res. Treat., 123 (2010),pp. 725-731
[11]	Jenko, S., Dolenc, I., Guncar, G. et al. Crystal structure of stefin A in complex with cathepsin H: N-terminal residues of inhibitors can adapt to the active sites of endo- and exopeptidases J. Mol. Biol., 326 (2003),pp. 875-885
[12]	Kolár, Z., Järvinen, M., Negrini, R. Demonstration of proteinase inhibitors cystatin A, B and C in breast cancer and in cell lines MCF-7 and ZR-75-1 Neoplasma, 36 (1989),pp. 185-189
[13]	Kuopio, T., Kankaanranta, A., Jalava, P. et al. Cysteine proteinase inhibitor cystatin A in breast cancer Cancer Res., 58 (1998),pp. 432-436
[14]	Lah, T.T., Clifford, J.L., Helmer, K.M. et al. Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma Biochim. Biophys. Acta, 993 (1989),pp. 63-73
[15]	Lah, T.T., Kokalj-Kunovar, M., Strukelj, B. et al. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma Int. J. Cancer, 50 (1992),pp. 36-44
[16]	Lah, T.T., Kos, J., Blejec, A. et al. The expression of lysosomal proteinases and their inhibitors in breast cancer: possible relationship to prognosis of the disease Pathol. Oncol. Res., 3 (1997),pp. 89-99
[17]	Lee, S., Stewart, S., Nagtegaal, I. et al. Cancer Res., 72 (2012),pp. 4574-4586
[18]	Levicar, N., Kos, J., Blejec, A. et al. Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients Cancer Detect. Prev., 26 (2002),pp. 42-49
[19]	Manjegowda, M.C., Deb, G., Kumar, N. et al. Expression profiling of genes modulated by estrogen, EGCG or both in MCF-7 breast cancer cells Genomics Data, 5 (2015),pp. 210-212
[20]	Mercado-Matos, J., Matthew-Onabanjo, A.N., Shaw, L.M. RUNX1 and breast cancer Oncotarget, 8 (2017),pp. 36934-36935
[21]	Nomura, T., Katunuma, N. Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells J. Med. Invest., 52 (2005),pp. 1-9
[22]	Parker, B., Ciocca, D., Bidwell, B. et al. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer J. Pathol., 214 (2008),pp. 337-346
[23]	Pazaiti, A., Fentiman, I.S. Basal phenotype breast cancer: implications for treatment and prognosis Womens Health (Lond. Engl.), 7 (2011),pp. 181-202
[24]	Rinne, A., Alavaikko, M., Järvinen, M. et al. Demonstration of immunoreactive acid cysteine-proteinase inhibitor in reticulum cells of lymph node germinal centres Virchows Arch. B. Cell Pathol. Incl. Mol. Pathol., 43 (1983),pp. 121-126
[25]	Rinne, A., Järvinen, M., Räsänen, O. A protein reminiscent of the epidermal SH-protease inhibitor occurs in squamous epithelia of man and rat Acta Histochem., 63 (1978),pp. 183-192
[26]	Rinne, A., Järvinen, M., Räsänen, O. et al. Acid and neutral cysteine proteinase inhibitor in normal uterine portio and in squamo-epithelial metaplasia, dysplasias and infiltrative carcinoma of the uterine portio Exp. Pathol., 26 (1984),pp. 67-70
[27]	Söderström, K.O., Laato, M., Wu, P. et al. Expression of acid cysteine proteinase inhibitor (ACPI) in the normal human prostate, benign prostatic hyperplasia and adenocarcinoma Int. J. Cancer, 62 (1995),pp. 1-4
[28]	Söderström, K.O., Rinne, R., Hopsu-Havu, V.K. et al. Identification of acid cysteine proteinase inhibitor (cystatin A) in the human thymus Anat. Rec., 240 (1994),pp. 115-119
[29]	Söderström, K.O., Rinne, R., Hopsu-Havu, V.K. et al. Hodgkin's disease: a malignancy of follicular dendritic cells? Lancet, 343 (1994),pp. 422-423
[30]	Vendrell, J.A., Magnino, F., Danis, E. et al. Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation J. Mol. Endocrinol., 32 (2004),pp. 397-414
[31]	Wakefield, L.M., Roberts, A.B. TGF-beta signaling: positive and negative effects on tumorigenesis Curr. Opin. Genet. Dev., 12 (2002),pp. 22-29
[32]	Zhang, M.H., Man, H.T., Zhao, X.D. et al. Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials Biomed. Rep., 2 (2014),pp. 41-52